Viewing Study NCT04392505


Ignite Creation Date: 2025-12-25 @ 3:32 AM
Ignite Modification Date: 2026-02-27 @ 12:49 AM
Study NCT ID: NCT04392505
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2024-02-29
First Post: 2020-05-08
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Durvalumab(MEDI4736) After chemoRadioTherapy(DART) for NSCLC-a Translational and Biomarker Study
Sponsor: Oslo University Hospital
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module